Updated:
Rose Research Center
The Rose Research Center is a medical research organization based in Raleigh, North Carolina. It conducts clinical trials and studies on smoking and nicotine.
Overview
The Rose Research Center is a medical research organization based in Raleigh, North Carolina. It conducts clinical trials and studies on smoking and nicotine. The center has made one investment, in Embera NeuroTherapeutics, through a grant on December 19, 2019.
General information
Location
Region
North America
Country
United States
City
Rockville
Corporate office
Rockville, MD, United States
Additional offices
Raleigh, NC, United States
Sector focus
Frequently asked questions
What services does Rose Research Center provide?
Rose Research Center offers clinical trial site services for Phase I through Phase IV studies. It handles patient recruitment, informed consent, study coordination, and data collection under contracts with pharmaceutical and biotech sponsors. It does not invest capital or manage assets.
Where are Rose Research Center's facilities located?
The firm has clinical trial sites in Rockville, Maryland, and Raleigh, North Carolina. No additional locations or international expansion plans are publicly documented.
Who are the leadership principals at Rose Research Center?
Rose Research Center does not publicly list its leadership team or board of directors. No named operators or investors are identified in public records.
Does Rose Research Center make direct investments or fund commitments?
No. The firm does not disclose any direct investment activity, fund-of-fund commitments, or co-investment partnerships. Its revenue model is fee-for-service from clinical trial sponsors, not capital deployment.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: